PKR (D7F7) Rabbit Monoclonal Antibody#12297,Cell Signaling Technology (CST),12297

PKR (D7F7) Rabbit Monoclonal Antibody recognizes endogenous levels of total PKR protein.

Host

Rabbit

Reactivity

Human

Application

Western Blotting: 1:1000 Simple WesternTM: 1:10 - 1:50 Immunoprecipitation: 1:50

Platform ID

BAB502370684

Cell Signaling Technology (CST)

Headquarters

3 Trask Lane Danvers, MA 01923

Contact

Tel: 877-616-2355,978-867-2388
Fax: 877-616-2355

Product Specifications
Scientific Background
Synonyms

Specifications

NamePKR (D7F7) Rabbit Monoclonal Antibody#12297
Cat. No.12297
Accession NumberP19525
Gene ID (Entrez)19525, 5610
HostRabbit
SensitivityEndogenous
ReactivityHuman
ApplicationWestern Blotting: 1:1000 Simple WesternTM: 1:10 - 1:50 Immunoprecipitation: 1:50
Molecular Weight74
ImmunogenIgG
FormulationSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.
StorageSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.
Regulatory StatusResearch Use Only

Scientific Background

Protein kinase R (PKR) is transcriptionally induced by interferon and activated by double-stranded RNA (dsRNA). PKR inhibits translation initiation through phosphorylation of the α subunit of the initiation factor eIF2 (eIF2α) and also controls the activation of several transcription factors, such as NF-κB, p53, and the Stats. In addition, PKR mediates apoptosis induced by many different stimuli, such as LPS, TNF-α, viral infection, and serum starvation (1,2). Activation of PKR by dsRNA results in PKR dimerization and autophosphorylation of Thr446 and Thr451 in the activation loop. Substitution of threonine for alanine at position 451 completely inactivated PKR, while a mutant with a threonine to alanine substitution at position 446 was partially active (3). Research studies have implicated PKR activation in the pathologies of neurodegenerative diseases, including Alzheimer's disease (4,5).Williams, B.R. (1999)Oncogene18, 6112-6120.Gil, J. and Esteban, M. (2000)Apoptosis5, 107-114.Romano, P. R. et al. (1998)Mol. Cell. Biol.18, 2282-2297.Peel, A.L. and Bredesen, D.E. (2003)Neurobiol Dis14, 52-62.Peel, A.L. (2004)J Neuropathol Exp Neurol63, 97-105.Alternate Namesdouble stranded RNA activated protein kinase; E2AK2; eIF-2A protein kinase 2; EIF2AK1; EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2; Eukaryotic translation initiation factor 2-alpha kinase 2; Interferon-induced, double-stranded RNA-activated protein kinase; interferon-inducible elF2alpha kinase; Interferon-inducible RNA-dependent protein kinase; LEUDEN; MGC126524; P1/eIF-2A protein kinase; p68 kinase; PKR; PPP1R83; PRKR; Protein kinase R; Protein kinase RNA-activated; protein kinase, interferon-inducible double stranded RNA dependent; protein phosphatase 1, regulatory subunit 83; Tyrosine-protein kinase EIF2AK2

Synonyms

double stranded RNA activated protein kinase; E2AK2; eIF-2A protein kinase 2; EIF2AK1; EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2; Eukaryotic translation initiation factor 2-alpha kinase 2; Interferon-induced, double-stranded RNA-activated protein kinase; interferon-inducible elF2alpha kinase; Interferon-inducible RNA-dependent protein kinase; LEUDEN; MGC126524; P1/eIF-2A protein kinase; p68 kinase; PKR; PPP1R83; PRKR; Protein kinase R; Protein kinase RNA-activated; protein kinase, interferon-inducible double stranded RNA dependent; protein phosphatase 1, regulatory subunit 83; Tyrosine-protein kinase EIF2AK2

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.